Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma

NCT00669136 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Poor accrual and limited target patient population for future accrual. Did not complete the Phase 1 portion of the trial.

Conditions

Hepatocellular Carcinoma
Hepatoma
Liver Cancer, Adult
Liver Cell Carcinoma
Liver Cell Carcinoma, Adult
Cancer of Liver
Cancer of the Liver
Cancer, Hepatocellular
Hepatic Cancer
Hepatic Neoplasms
Hepatocellular Cancer
Liver Cancer
Neoplasms, Hepatic
Neoplasms, Liver

Interventions

DRUG: AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost

Sponsor

Lisa H. Butterfield, Ph.D.

Collaborators

[object Object]